Form 4 Tracker
Martine A Rothblatt

Director; Director, Chairperson & CEO · 81 filings · Latest: Jun 17, 2026

BETA Technologies, Inc.
UNITED THERAPEUTICS Corp
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
UTHR
Martine A RothblattDirector, Chairperson & CEOMay 21, 2026
Option Exercise
$146.039,500$1.4M50,013
UTHR
Martine A RothblattDirector, Chairperson & CEOMay 20, 2026
Sale
$565.989,500$5.4M40,513
UTHR
Martine A RothblattDirector, Chairperson & CEOMay 20, 2026
Option Exercise
$146.039,500$1.4M50,013
UTHR
Martine A RothblattDirector, Chairperson & CEOMay 19, 2026
Sale
$567.949,500$5.4M40,513
UTHR
Martine A RothblattDirector, Chairperson & CEOMay 19, 2026
Option Exercise
$146.039,500$1.4M50,013
UTHR
Martine A RothblattDirector, Chairperson & CEOMay 18, 2026
Sale
$567.049,500$5.4M40,513
UTHR
Martine A RothblattDirector, Chairperson & CEOMay 18, 2026
Option Exercise
$146.039,500$1.4M50,013
UTHR
Martine A RothblattDirector, Chairperson & CEOMay 15, 2026
Sale
$568.119,500$5.4M40,513
UTHR
Martine A RothblattDirector, Chairperson & CEOMay 15, 2026
Option Exercise
$146.039,500$1.4M50,013
UTHR
Martine A RothblattDirector, Chairperson & CEOMay 14, 2026
Sale
$574.489,500$5.5M40,513
UTHR
Martine A RothblattDirector, Chairperson & CEOMay 14, 2026
Option Exercise
$146.039,500$1.4M50,013
UTHR
Martine A RothblattDirector, Chairperson & CEOMay 13, 2026
Sale
$578.659,500$5.5M40,513
UTHR
Martine A RothblattDirector, Chairperson & CEOMay 13, 2026
Option Exercise
$146.039,500$1.4M50,013
UTHR
Martine A RothblattDirector, Chairperson & CEOMay 12, 2026
Sale
$578.389,500$5.5M40,513
UTHR
Martine A RothblattDirector, Chairperson & CEOMay 12, 2026
Option Exercise
$146.039,500$1.4M50,013
UTHR
Martine A RothblattDirector, Chairperson & CEOMay 11, 2026
Sale
$573.109,500$5.4M40,513
UTHR
Martine A RothblattDirector, Chairperson & CEOMay 11, 2026
Option Exercise
$146.039,500$1.4M50,013
UTHR
Martine A RothblattDirector, Chairperson & CEOMay 8, 2026
Sale
$564.959,500$5.4M40,513
UTHR
Martine A RothblattDirector, Chairperson & CEOMay 8, 2026
Option Exercise
$146.039,500$1.4M50,013
UTHR
Martine A RothblattDirector, Chairperson & CEOMay 7, 2026
Sale
$578.549,500$5.5M40,513